386 related articles for article (PubMed ID: 28912574)
1. Distinct gut microbiome patterns associate with consensus molecular subtypes of colorectal cancer.
Purcell RV; Visnovska M; Biggs PJ; Schmeier S; Frizelle FA
Sci Rep; 2017 Sep; 7(1):11590. PubMed ID: 28912574
[TBL] [Abstract][Full Text] [Related]
2. MinION Sequencing of colorectal cancer tumour microbiomes-A comparison with amplicon-based and RNA-Sequencing.
Taylor WS; Pearson J; Miller A; Schmeier S; Frizelle FA; Purcell RV
PLoS One; 2020; 15(5):e0233170. PubMed ID: 32433701
[TBL] [Abstract][Full Text] [Related]
3. Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer.
Osman MA; Neoh HM; Ab Mutalib NS; Chin SF; Mazlan L; Raja Ali RA; Zakaria AD; Ngiu CS; Ang MY; Jamal R
Sci Rep; 2021 Feb; 11(1):2925. PubMed ID: 33536501
[TBL] [Abstract][Full Text] [Related]
4. Metagenomics and transcriptomics data from human colorectal cancer.
Visnovska T; Biggs PJ; Schmeier S; Frizelle FA; Purcell RV
Sci Data; 2019 Jul; 6(1):116. PubMed ID: 31278253
[TBL] [Abstract][Full Text] [Related]
5. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer.
Yu J; Feng Q; Wong SH; Zhang D; Liang QY; Qin Y; Tang L; Zhao H; Stenvang J; Li Y; Wang X; Xu X; Chen N; Wu WK; Al-Aama J; Nielsen HJ; Kiilerich P; Jensen BA; Yau TO; Lan Z; Jia H; Li J; Xiao L; Lam TY; Ng SC; Cheng AS; Wong VW; Chan FK; Xu X; Yang H; Madsen L; Datz C; Tilg H; Wang J; Brünner N; Kristiansen K; Arumugam M; Sung JJ; Wang J
Gut; 2017 Jan; 66(1):70-78. PubMed ID: 26408641
[TBL] [Abstract][Full Text] [Related]
6. The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis.
Conde-Pérez K; Aja-Macaya P; Buetas E; Trigo-Tasende N; Nasser-Ali M; Rumbo-Feal S; Nión P; Arribas EM; Estévez LS; Otero-Alén B; Noguera JF; Concha Á; Pardiñas-López S; Carda-Diéguez M; Gómez-Randulfe I; Martínez-Lago N; Ladra S; Aparicio LMA; Bou G; Mira Á; Vallejo JA; Poza M
Mol Oncol; 2024 May; 18(5):1093-1122. PubMed ID: 38366793
[TBL] [Abstract][Full Text] [Related]
7. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers.
Dai Z; Coker OO; Nakatsu G; Wu WKK; Zhao L; Chen Z; Chan FKL; Kristiansen K; Sung JJY; Wong SH; Yu J
Microbiome; 2018 Apr; 6(1):70. PubMed ID: 29642940
[TBL] [Abstract][Full Text] [Related]
8. The prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial.
Mooi JK; Wirapati P; Asher R; Lee CK; Savas P; Price TJ; Townsend A; Hardingham J; Buchanan D; Williams D; Tejpar S; Mariadason JM; Tebbutt NC
Ann Oncol; 2018 Nov; 29(11):2240-2246. PubMed ID: 30247524
[TBL] [Abstract][Full Text] [Related]
9. Biodiversity and richness shifts of mucosa-associated gut microbiota with progression of colorectal cancer.
Pan HW; Du LT; Li W; Yang YM; Zhang Y; Wang CX
Res Microbiol; 2020; 171(3-4):107-114. PubMed ID: 31982498
[TBL] [Abstract][Full Text] [Related]
10. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
[TBL] [Abstract][Full Text] [Related]
11. Consensus molecular subtype classification of colorectal adenomas.
Komor MA; Bosch LJ; Bounova G; Bolijn AS; Delis-van Diemen PM; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; van Grieken NC; Carvalho B; Wessels LF; Jimenez CR; Fijneman RJ; Meijer GA;
J Pathol; 2018 Nov; 246(3):266-276. PubMed ID: 29968252
[TBL] [Abstract][Full Text] [Related]
12. A modified protein marker panel to identify four consensus molecular subtypes in colorectal cancer using immunohistochemistry.
Li X; Larsson P; Ljuslinder I; Ling A; Löfgren-Burström A; Zingmark C; Edin S; Palmqvist R
Pathol Res Pract; 2021 Apr; 220():153379. PubMed ID: 33721619
[TBL] [Abstract][Full Text] [Related]
13. Enrichment of Prevotella intermedia in human colorectal cancer and its additive effects with Fusobacterium nucleatum on the malignant transformation of colorectal adenomas.
Lo CH; Wu DC; Jao SW; Wu CC; Lin CY; Chuang CH; Lin YB; Chen CH; Chen YT; Chen JH; Hsiao KH; Chen YJ; Chen YT; Wang JY; Li LH
J Biomed Sci; 2022 Oct; 29(1):88. PubMed ID: 36303164
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of TSPAN8 in consensus molecular subtype 3 colorectal cancer.
Suwatthanarak T; Tanjak P; Chaiboonchoe A; Acharayothin O; Thanormjit K; Chanthercrob J; Suwatthanarak T; Niyomchan A; Tanaka M; Okochi M; Pongpaibul A; Chalermwai WV; Trakarnsanga A; Methasate A; Pithukpakorn M; Chinswangwatanakul V
Exp Mol Pathol; 2024 Jun; 137():104911. PubMed ID: 38861838
[TBL] [Abstract][Full Text] [Related]
15. Microbiome confounders and quantitative profiling challenge predicted microbial targets in colorectal cancer development.
Tito RY; Verbandt S; Aguirre Vazquez M; Lahti L; Verspecht C; Lloréns-Rico V; Vieira-Silva S; Arts J; Falony G; Dekker E; Reumers J; Tejpar S; Raes J
Nat Med; 2024 May; 30(5):1339-1348. PubMed ID: 38689063
[TBL] [Abstract][Full Text] [Related]
16. Parvimonas micra is associated with tumour immune profiles in molecular subtypes of colorectal cancer.
Löwenmark T; Li X; Löfgren-Burström A; Zingmark C; Ling A; Kellgren TG; Larsson P; Ljuslinder I; Wai SN; Edin S; Palmqvist R
Cancer Immunol Immunother; 2022 Oct; 71(10):2565-2575. PubMed ID: 35301576
[TBL] [Abstract][Full Text] [Related]
17. Fusobacterium nucleatum in biopsied tissues from colorectal cancer patients and alcohol consumption in Korea.
Kim M; Lee ST; Choi S; Lee H; Kwon SS; Byun JH; Kim YA; Rhee KJ; Choi JR; Kim TI; Lee K
Sci Rep; 2020 Nov; 10(1):19915. PubMed ID: 33199749
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain.
Allali I; Delgado S; Marron PI; Astudillo A; Yeh JJ; Ghazal H; Amzazi S; Keku T; Azcarate-Peril MA
Gut Microbes; 2015; 6(3):161-72. PubMed ID: 25875428
[TBL] [Abstract][Full Text] [Related]
19. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic subtypes predict outcomes in colorectal cancer.
Kasurinen J; Beilmann-Lehtonen I; Kaprio T; Hagström J; Haglund C; Böckelman C
Acta Oncol; 2023 Mar; 62(3):245-252. PubMed ID: 36867078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
